MedPage Today) — A single intravitreal injection of UBX1325 (foselutoclax), a novel senolytic small molecule inhibitor, had a tolerable safety profile and “trends suggestive of potential efficacy” in patients with diabetic macular edema (DME…
Alternative to Anti-VEGF Shows Safety, Efficacy in Diabetic Macular Edema

Leave a Comment Leave a Comment
